Skylight Health Announces Appointment of Dr. Kit Brekhus as Chief Medical Officer
July 07 2021 - 6:00AM
Skylight Health Group Inc. (NASDAQ: SLHG; TSXV:SLHG) (“Skylight
Health” or the “Company”), a multi-state primary care management
group in the United States, today announced the appointment of Dr.
Kit Brekhus, MD, as Chief Medical Officer (CMO). Dr. Brekhus will
be taking the position over from Dr. Georges Feghali who served as
CMO from February 2021. Dr. Feghali will continue to serve as an
advisor to the Company.
As a board-certified family physician, Dr. Brekhus brings a
wealth of experience to Skylight Health and a passion for improving
patient care. In a career spanning more than 25 years, Dr. Brekhus
has worked as both a clinician and owner-operator of a
free-standing family practice and full-service urgent care center.
He served as the Medical Director of Outreach services for a large
healthcare system and helped lead the growth and development of the
Colorado Community Health Alliance as their inaugural Chief Medical
Officer.
More recently, prior to joining Skylight Health, Dr. Brekhus
served several years as founding board member, physician director,
and chief medical executive for one of the largest clinically
integrated networks in the Rocky Mountain region dedicated to
advancing value-based care. In that role he was responsible for
overseeing a network of more than 5,000 providers serving as one of
four executives managing more than 250,000 lives in various
value-based agreements.
“Dr. Brekhus’ knowledge and experience as a clinical leader, in
building large provider networks and value-based care programs will
support Skylight’s vision of a patient centered model for
healthcare,” said Dr. Feghali. “As my role was to initially help
develop many of the foundational pieces of clinical leadership
within the Company, I am happy to see this work continue now with
Dr. Brekhus, and I look forward to remaining actively engaged as an
advisor with the Company.”
“I’m excited to join the Skylight team. I want to thank Dr.
Feghali for the foundation he has built and the executive team at
Skylight for their leadership. They’ve created something very
special at Skylight Health,” said Dr. Brekhus. “My entire career
has been focused on advancing primary care, building large,
clinically integrated networks of providers, and working directly
with payors and plan sponsors in creating value-based programs;
programs that truly make a difference in people’s lives. I’m
looking forward to getting out to our offices soon; to meeting our
providers, getting to know our team members, and continuing the
work, already underway, of creating value for the people we
serve.”
“The Skylight team would like to personally thank Dr. Feghali
for all his efforts and work over the last few months in helping us
establish a leading clinical team and organization,” said Prad
Sekar, Skylight Health, CEO. “We wish him all the best in his new
international endeavours and are thrilled he has agreed to continue
on with the Company in an active advisory role.”
ABOUT SKYLIGHT HEALTH GROUP INC.
Skylight Health Group (NASDAQ:SLHG;TSXV:SLHG) is a healthcare
services and technology company, working to positively impact
patient health outcomes. The Company operates a US multi-state
primary care health network comprised of physical practices
providing a range of services from primary care, sub-specialty,
allied health, and laboratory/diagnostic testing. The Company is
focused on helping small and independent practices shift from a
traditional fee-for-service (FFS) model to value-based care (VBC)
through tools including proprietary technology, data analytics and
infrastructure. In a FFS model, payors (commercial and government
insurers) reimburse on an encounter-based approach. This puts a
focus on volume of patients per day. In a VBC model, the providers
offer care that is aimed at keeping patients healthy and minimize
unnecessary health expenditures that are not proven to maintain the
patient’s well-being. This places an emphasis on quality over
volume. VBC will lead to improved patient outcomes, reduced cost of
delivery and drive stronger financial performance from existing
practices.
FORWARD LOOKING STATEMENTS
This press release may include predictions, estimates or other
information that might be considered forward-looking within the
meaning of applicable securities laws. While these forward-looking
statements represent our current judgments, they are subject to
risks and uncertainties that could cause actual results to differ
materially. You are cautioned not to place undue reliance on these
forward-looking statements, which reflect our opinions only as of
the date of this release. Please keep in mind that we are not
obligating ourselves to revise or publicly release the results of
any revision to these forward-looking statements in light of new
information or future events. When used herein, words such as "look
forward," "believe," "continue," "building," or variations of such
words and similar expressions are intended to identify
forward-looking statements. Factors that could cause actual results
to differ materially from those contemplated in any forward-looking
statements made by us herein are often discussed in filings we make
with the Canadian and United States securities regulators,
including the Securities and Exchange Commission, available at:
www.sec.gov, and Canadian Securities Administrators, available at
www.sedar.com, and on our website, at skylighthealthgroup.com.
For more information, please visit our website or contact:
Investor Relations – USA:John
Evansjohn.evans@skylighthealthgroup.com415-309-0230
Investor Relations - Canada: Jackie
Kellyinvestors@skylighthealthgroup.com416-301-2949
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Skylight Health (TSXV:SLHG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Skylight Health (TSXV:SLHG)
Historical Stock Chart
From Jul 2023 to Jul 2024